CME and CFTC Lock Horns Over On-Chain Perpetual Futures

The dispute between the CME Group and the US Commodity Futures Trading Commission (CFTC) has escalated into a full-blown battle, with the CME suing the CFTC and its chairman, Mike Selig, over the regulator's decision to allow the listing of crypto perpetual futures. The CME claims that these products are harmful to its traditional futures contracts and that the CFTC's approval was made without proper consideration of the implications. The CFTC, on the other hand, argues that the CME is trying to stifle competition and innovation in the derivatives market. The outcome of this battle could have significant implications for the US approach to the rapidly growing market for perpetual futures, which has already seen volumes reach $60 trillion globally. The CME's lawsuit challenges the CFTC's decision to allow the listing of crypto perps by Kalshi and Coinbase, claiming that these products are swaps and should be subject to stricter regulations. The CFTC, however, has determined that a case-by-case review process is sufficient for these products, and has approved Kalshi's debut offering, which reached over $1 billion in trading volume in less than a week. The CME's CEO, Terry Duffy, has been vocal in his criticism of the CFTC's approach, arguing that the regulator is not prepared to enforce its emerging perps policy properly and that the products are not suitable for traditional commodities. The battle between the CME and the CFTC is being closely watched by industry experts, who see it as a test of the regulator's ability to balance innovation with investor protection. The outcome of the lawsuit could have far-reaching implications for the US derivatives market and the development of perpetual futures products.